Kamada (KMDA) Gains from Investment Securities (2012 - 2026)
Kamada (KMDA) reported Gains from Investment Securities of -$44000.0 for Q1 2026, down 450.0% on a YoY basis from $12571.4 in Q1 2025, and down 112.54% quarter-over-quarter from $351000.0 in Q4 2025.
Kamada (KMDA) Gains from Investment Securities (2012 - 2026) Analysis & Trends
Kamada has reported Gains from Investment Securities for 15 years, with the latest figure at -$44000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities fell 450.0% year-over-year to -$44000.0; the trailing twelve-month figure through Mar 2026 stood at $451000.0 (up 213.19% YoY), and the FY2025 full-year result was -$8000.0, down 100.24% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at -$44000.0, down from $351000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $2.7 million in Q4 2023, with the low at -$94000.0 in Q2 2023.
- Historically, Gains from Investment Securities has averaged $180232.9 across 5 years, with a median of -$1000.0 in 2024.
- The largest YoY upside for Gains from Investment Securities was 29622322.22% in 2023 against a maximum downside of 688788.89% in 2023.
- Kamada's Gains from Investment Securities stood at -$9.0 in 2022, then jumped by 29622322.22% to $2.7 million in 2023, then tumbled by 94.71% to $141000.0 in 2024, then surged by 148.94% to $351000.0 in 2025, then slumped by 112.54% to -$44000.0 in 2026.
- The last three Gains from Investment Securities figures came in at -$44000.0 (Q1 2026), $351000.0 (Q4 2025), and -$13000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44,000.00 |
| Mar 31, 2026 | -44,000.00 |
| Dec 31, 2025 | 351,000.00 |
| Dec 31, 2025 | 351,000.00 |
| Sep 30, 2025 | -13,000.00 |
| Sep 30, 2025 | -13,000.00 |
| Jun 30, 2025 | 157,000.00 |
| Jun 30, 2025 | 157,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Dec 31, 2024 | 141,000.00 |
| Dec 31, 2024 | 141,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | -23,000.00 |
| Mar 31, 2024 | -23,000.00 |
| Dec 31, 2023 | 2.67 Mn |
| Dec 31, 2023 | 2.67 Mn |